5-Heptenoic acid, 7-(4-butyloctahydro-2,5-dioxo-1H-inden-1-yl)- (BioDeep_00000911262)

   


代谢物信息卡片


5-Heptenoic acid, 7-(4-butyloctahydro-2,5-dioxo-1H-inden-1-yl)-

化学式: C20H30O4 (334.2144)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CCCCC1C2CC(=O)C(C2CCC1=O)CC=CCCCC(=O)O
InChI: InChI=1S/C20H30O4/c1-2-3-8-16-17-13-19(22)15(14(17)11-12-18(16)21)9-6-4-5-7-10-20(23)24/h4,6,14-17H,2-3,5,7-13H2,1H3,(H,23,24)/b6-4+

描述信息

同义名列表

1 个代谢物同义名

5-Heptenoic acid, 7-(4-butyloctahydro-2,5-dioxo-1H-inden-1-yl)-



数据库引用编号

2 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Paolo C Colombo, Javier E Banchs, Sulejman Celaj, Ashok Talreja, Justine Lachmann, Shailesh Malla, Nicholas B DuBois, Anthony W Ashton, Farhana Latif, Ulrich P Jorde, J Anthony Ware, Thierry H LeJemtel. Endothelial cell activation in patients with decompensated heart failure. Circulation. 2005 Jan; 111(1):58-62. doi: 10.1161/01.cir.0000151611.89232.3b. [PMID: 15611373]
  • S Zacharieva, M Andreeva, M Orbetzova, M Wippermann, I Mucha, K Andonova, S Sheitanova. Effects of corticotropin-releasing hormone on ACTH, cortisol and 13, 14-dihydro-15-keto prostaglandin E2 in patients with diabetes insipidus before and after captopril treatment. Prostaglandins, leukotrienes, and essential fatty acids. 1996 Jun; 54(6):433-7. doi: 10.1016/s0952-3278(96)90027-7. [PMID: 8888355]
  • S Zacharieva, S Torbova, M Orbetzova, A M Borissova, K Andonova, S Sheitanova. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension. Methods and findings in experimental and clinical pharmacology. 1996 Apr; 18(3):205-9. doi: NULL. [PMID: 8738072]
  • C O Pirttikangas, M Salo, A Riutta, J Perttilä, O Peltola, O Kirvela. Effects of propofol and Intralipid on immune response and prostaglandin E2 production. Anaesthesia. 1995 Apr; 50(4):317-21. doi: 10.1111/j.1365-2044.1995.tb04607.x. [PMID: 7747848]
  • F Fairlie, G Phillips, M McLaren, A Calder, J Walker. Uterine activity in spontaneous labour and maternal peripheral plasma prostaglandin E2 and F2 alpha metabolites. Journal of perinatal medicine. 1993; 21(1):35-42. doi: 10.1515/jpme.1993.21.1.35. [PMID: 8487148]
  • F M Fairlie, G D Lang, I A Greer, M McLaren. Umbilical artery Doppler flow velocity waveforms and maternal prostaglandin E2 and F2 alpha metabolite concentrations during cervical ripening with prostaglandin E2. European journal of obstetrics, gynecology, and reproductive biology. 1990 Oct; 37(1):7-13. doi: 10.1016/0028-2243(90)90089-j. [PMID: 2198178]
  • A Nell, H Porteder, M Matejka, H Sinzinger. The optimal processing of plasma samples for the determination of bicyclo-PGE in patients with malignant maxillofacial tumors. Prostaglandins, leukotrienes, and essential fatty acids. 1989 Jun; 36(3):143-7. doi: 10.1016/0952-3278(89)90053-7. [PMID: 2780759]
  • H Sinzinger, I Virgolini, F Rauscha, P Fitscha. Glucocorticoid-treatment does not influence the synthesis of thromboxane B2 and bicyclo-PGE2 in humans. Prostaglandins, leukotrienes, and essential fatty acids. 1989 Mar; 35(3):135-9. doi: 10.1016/0952-3278(89)90114-2. [PMID: 2710797]
  • B Stanek, C Punzengruber, K Silberbauer. Increase in bicycloprostaglandin E2 metabolite in congestive heart failure in response to captopril. Clinical cardiology. 1989 Feb; 12(2):97-101. doi: 10.1002/clc.4960120206. [PMID: 2653680]
  • A M Hendrick, M D Mitchell, A L Harris. Plasma prostaglandins in lung cancer. European journal of cancer & clinical oncology. 1988 Jun; 24(6):1069-71. doi: 10.1016/0277-5379(88)90161-7. [PMID: 3409943]
  • N J Alexander, T H Tarter, D L Fulgham, C A Ducsay, M J Novy. Rectal infusion of semen results in transient elevation of blood prostaglandins. American journal of reproductive immunology and microbiology : AJRIM. 1987 Oct; 15(2):47-51. doi: 10.1111/j.1600-0897.1987.tb00151.x. [PMID: 3434658]
  • W M Wolfe, C V Rao, E M McCracken, L M Demers. Peripheral prostaglandin metabolite levels in women undergoing therapeutic abortions in the first trimester with and without treatment with prostaglandin synthetase inhibitor. Prostaglandins, leukotrienes, and medicine. 1987 Jun; 28(1):53-9. doi: 10.1016/0262-1746(87)90047-3. [PMID: 3112807]
  • W M Wolfe, C V Rao, E McCracken, L M Demers, K C Huang, K Tsueda. Peripheral plasma levels of prostaglandin metabolites, cortisol and prolactin in women undergoing falope ring application and tubal cautery. Prostaglandins, leukotrienes, and medicine. 1986 Nov; 25(1):31-8. doi: 10.1016/0262-1746(86)90098-3. [PMID: 3467383]
  • D M Strickland, P R Ziaya, J H McCubbin, R M Rybarczyk, T M Rayfield, M D Mitchell. Prostaglandin E metabolite levels in umbilical cord plasma. Prostaglandins, leukotrienes, and medicine. 1986 Nov; 25(1):51-2. doi: 10.1016/0262-1746(86)90101-0. [PMID: 3467385]
  • F A Kimball, P L Ruppel, M L Noah, J M Decoster, P delaFuente, J M Castillo, J M Hernandez. The effect of endocervical PGE2-gel (Prepidil) gel on plasma levels of 13,14-dihydro-15-keto-PGE2 (PGEM) in women at term. Prostaglandins. 1986 Oct; 32(4):527-37. doi: 10.1016/0090-6980(86)90035-3. [PMID: 3541062]
  • A A Mathé, G Eberhard, J Sääf, L Wetterberg. Plasma prostaglandin E2 metabolite--measured as 11-deoxy-15-keto-13,14-dihydro-11 beta,16 xi-cyclo-PGE2--in twins with schizophrenic disorder. Biological psychiatry. 1986 Sep; 21(11):1024-30. doi: 10.1016/0006-3223(86)90283-0. [PMID: 3741918]
  • C Punzengruber, B Stanek, H Sinzinger, K Silberbauer. Bicyclo-prostaglandin E2 metabolite in congestive heart failure and relation to vasoconstrictor neurohumoral principles. The American journal of cardiology. 1986 Mar; 57(8):619-23. doi: 10.1016/0002-9149(86)90846-5. [PMID: 3513522]
  • S P Brennecke, B M Castle, L M Demers, A C Turnbull. Maternal plasma prostaglandin E2 metabolite levels during human pregnancy and parturition. British journal of obstetrics and gynaecology. 1985 Apr; 92(4):345-9. doi: 10.1111/j.1471-0528.1985.tb01107.x. [PMID: 3857076]
  • K Silberbauer, C Punzengruber, H Sinzinger. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure. Cardiology. 1983; 70(6):297-307. doi: 10.1159/000173612. [PMID: 6370431]
  • M D Mitchell, K Ebenhack, D L Kraemer, K Cox, S Cutrer, D M Strickland. A sensitive radioimmunoassay for 11-deoxy-13, 14-dihydro-15-keto-11, 16-cyclo-prostaglandin E2: application as an index of prostaglandin E2 biosynthesis during human pregnancy and parturition. Prostaglandins, leukotrienes, and medicine. 1982 Nov; 9(5):549-57. doi: 10.1016/0262-1746(82)90036-1. [PMID: 6960378]
  • E Granström, M Hamberg, G Hansson, H Kindahl. Chemical instability of 15-keto-13,14-dihydro-PGE2: the reason for low assay reliability. Prostaglandins. 1980 Jun; 19(6):933-57. doi: 10.1016/0090-6980(80)90127-6. [PMID: 7384561]